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Abstract
Curcumin is a natural active principle with antioxidant, antibacterial and anti-inflammatory properties. Its use is limited by a
low water solubility and fast degradation rate, which hinder its bioavailability. To overcome this problem, curcumin can be
delivered through a carrier, which protects the drug molecule and enhances its pharmacological effects. The present work
proposes a simple one-pot sol–gel synthesis to obtain a hybrid carrier for curcumin delivery. The hybrid consists of a
mesostructured matrix of amorphous silica, which stabilizes the carrier, and hexadecyltrimethylammonium (CTA), a
surfactant where curcumin is dissolved to increase its water solubility. The carrier was characterized in terms of morphology
(FESEM), physicochemical properties (XRD, FTIR, UV spectroscopy) and release capability in pseudo-physiological
solutions. Results show that curcumin molecules were entrapped, for the first time, in a silica-surfactant mesostructured
hybrid carrier. The hybrid carrier successfully released curcumin in artificial sweat and in a phosphate buffer saline solution,
so confirming its efficacy in increasing curcumin water solubility. The proposed drug release mechanism relies on the
degradation of the carrier, which involves the concurrent release of silicon. This suggests strong potentialities for topical
administration applications, since curcumin is effective against many dermal diseases while silicon is beneficial to the skin.
Graphical Abstract
A simple one-pot sol–gel organic-solvent-free synthesis, at room temperature, leads to the formation of a hybrid
mesostructured CTA–silica containing curcumin. When in pseudo-physiological solutions, the hybrid releases curcumin
(enclosed in surfactant micelles), with enhanced solubility, and silicates. This material is a promising candidate for topical
administration of drugs, since curcumin is effective against several dermatological diseases and silicon is beneficial to skin.
* Marta Gallo
marta.gallo@polito.it
1 Dipartimento di Scienza Applicata e Tecnologia, Politecnico di
Torino, Corso Duca degli Abruzzi, 24, 10129 Torino, Italy
12
34
56
78
90
()
;,:
12
34
56
78
90
();
,:
Keywords Drug carrier ● Hybrid ● Curcumin ● Silica ● Mesostructured ● Topical application
Highlights
● A novel mesostructured curcumin-containing hybrid carrier was successfully synthesized.
● The hybrid enhances curcumin solubility in pseudo-physiological conditions (e.g., artificial sweat).
● Curcumin release is governed by a degradation process of the silica matrix.
● Degradation of the hybrid induces the simultaneous release of curcumin, silicates, and surfactant.
1 Introduction
Curcumin, a natural polyphenol derived from the turmeric
rhizome, is also known as the “golden spice”, because of its
beneficial properties, which are widely recognized by tra-
ditional Asian medicine. However, also modern science has
confirmed the effectiveness of curcumin against numerous
diseases. Thanks to its functional groups (two aromatic
phenolic rings and an α-β-diketo moiety), curcumin can act
as a scavenger of reactive oxygen species and bind (cova-
lently or not) to biomolecules [1]. This confers curcumin its
unique antibacterial, anti-inflammatory, antioxidant, and
wound healing properties as well as significant anticancer
activity [2]. In recent years, curcumin has also been proved
to be effective for skin disorders, such as psoriasis and
dermatoses [3–5], and to be particularly useful to treat
chronic diseases since, being it a natural molecule, it does
not induce side effects even at high doses and for long-term
treatments.
However, the use of curcumin is still strongly limited by
its poor bioavailability, poor water solubility, and fast
degradation rate (particularly in alkaline solutions and in the
presence of light) [1]. To overcome these limitations,
researchers have proposed to deliver curcumin by means of
appropriate carriers, which are able to protect the molecule
from degradation and to enhance its water solubility and
bioavailability. The suggested solutions include liposomes,
solid-lipid nanoparticles, polymeric nanoparticles, micelles,
and mesoporous silica [5–11]. In particular, previous studies
showed that micelles, which are assemblies of surfactant
molecules with an inner hydrophobic core and an external
hydrophilic layer, can enclose the highly hydrophobic cur-
cumin, so protecting it from alkali degradation and
increasing its water solubility and bioavailability [6, 8, 12].
Furthermore, Dhivya et al. have recently exploited the
hydrophobicity of a polymer shell to incorporate curcumin
in ZnO particles with anti-gastric cancer activity [11].
On the other hand, in recent years, nanoparticles of dif-
ferent materials (e.g., silica [13], metal oxide [11]) have
been investigated as potential drug carriers and their prop-
erties have been extensively studied. In particular, meso-
porous silica particles, with pore size ranging between 2 and
50 nm in diameter appear to be a valid substitute for
traditional drug carriers, thanks to their versatility [13].
Indeed, mesoporous silica carriers can be loaded with cur-
cumin, which can afterwards be released in a sustained way,
so enhancing its pharmacological effects [10]. In particular,
when constrained in mesopores, curcumin loses its crys-
tallinity and turns into an amorphous form, so becoming
more water soluble and, therefore, more bioavailable. The
incorporation of curcumin in mesoporous silica, however,
can be laborious. Indeed, curcumin can be incorporated by
impregnation techniques [10, 14], which imply the use of
harmful solvents, such as methanol or ethanol. The use of a
safer alternative solvent, such as supercritical CO2 (scCO2),
which does not present any toxicity issues, is not suitable,
because curcumin has such a low solubility (10−8 molar
fraction) in scCO2 [15], that this technique is inappropriate
to achieve significant drug loading of the carrier.
Eventually, another possible approach reported in the
literature consists in synthetizing silica nanoparticles
directly in the presence of curcumin [16]. The obtained
hybrid material, however, contains crystalline rather than
amorphous curcumin and, therefore, does not exploit the
potential benefits of curcumin amorphization induced by the
incorporation in a silica matrix.
In order to overcome the above-cited problems, a
mesostructured hybrid carrier is here proposed, which joins
the advantages of micelles (drug protection and increase of
water solubility) with those of amorphous silica (higher
stability and possible release of silicon as orthosilicic acid).
The same objective has also been attempted by other
research groups [17, 18]. Kerkhofs et al. for example,
synthesized silica capsules that contained micelles of P123,
a surfactant able to enclose the anti-inflammatory drug
flurbiprofen [17]. Also Chin and coworkers [18] synthe-
sized a hybrid material containing hexadecyl-
trimethylammonium bromide (CTAB) as a surfactant,
curcumin, and iron oxide nanoparticles for a targeted drug
delivery. However, this last synthesis was carried out in an
acidic environment, required a long time (i.e., days) and
involved the use of formamide, a toxic reagent [19]. In the
present work, a similar approach has been followed, using
CTAB as a surfactant, but different synthesis conditions
(namely alkaline) and no harmful organic solvents were
employed to enclose curcumin as a model drug. To the
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knowledge of the authors, this is the first time that curcumin
is incorporated in such a hybrid carrier. Interestingly, such a
carrier could be exploited also for the incorporation of other
hydrophobic drugs, different from curcumin.
With the aim of following a bottom-up approach and
avoiding curcumin degradation, a mild, fast, and simple
sol–gel synthesis was selected, which operated at room
temperature, and in an organic-solvent-free aqueous med-
ium. The carrier was prepared by adapting previous litera-
ture synthesis processes [20, 21], which led to the
production of a hybrid mesostructured silica, in which the
mesopores still contained the surfactant and curcumin. Two
materials were synthesized: a reference hybrid mesos-
tructured silica without curcumin and another one contain-
ing curcumin. The so-obtained materials were fully
characterized in terms of morphology (field emission
scanning electron microscopy analyses, FESEM) and of
physicochemical properties (X-ray diffraction, XRD, Four-
ier infrared, FTIR, and UV–Visible spectroscopy on the
solid). In addition, preliminary release tests in fluids simu-
lating different physiological conditions, such as skin sur-
face, gastric, and plasma environment, were performed.
2 Materials and methods
2.1 Synthesis
Mesostructured silica was obtained through a synthesis
process inspired by previous works reported in the literature
[20, 21]. All reagents were purchased from Sigma-Aldrich
(Milano, Italy) and used as received. Briefly, 0.40 g of
hexadecyltrimethylammonium bromide (CTAB) were
added under constant stirring (150 rpm) to a 0.05M solution
of NaOH (0.19 g of NaOH in 95 mL of distilled water).
After 40–50 min, 31.7 mg of curcumin (Cur) were added
and solubilized for 5 min. Afterwards, 2 mL of tetraethyl
orthosilicate (TEOS) were added dropwise. The solution,
which turned into a colored slurry, was left under stirring
for 3 h. Then the precipitate was filtered from the solution,
washed with distilled water, and let dry in air inside an oven
at 40 °C overnight until constant weight. When the
curcumin-free reference material was prepared, the proce-
dure was the same except that no curcumin was added. The
final molar ratios for the reference and the curcumin-loaded
materials were, respectively: 1 TEOS:0.122 CTAB:0.536
NaOH:589 H2O and 1 TEOS:0.122 CTAB:0.536
NaOH:0.02 Cur:589 H2O.
2.2 Characterization
Once ground, the previously obtained powders underwent
XRD analyses in a Panalytical X’Pert PRO (Cu Kα
radiation, Malvern Panalytical, Almelo, The Neatherlands).
Data collection has been performed at 40 kV and 40 mA,
with a solid-state detector (PIXcel1D) at small and high
angles (2θ= 0.7°–10° and 2θ= 5°–60° respectively).
Morphology of Pt-metallized specimens was observed with
a FESEM Zeiss Merlin (Oxford Instruments, Abingdon-on-
Thames, UK). FTIR spectra were recorded at a resolution of
2 cm−1 on pelletized powders (with the addition of KBr)
with an Equinox 55 spectrometer (Bruker, Billerica, MA,
USA) after outgassing the sample at room temperature
(residual pressure of 0.1 Pa). UV–Vis spectroscopy analyses
on powders were performed with a Varian Cary
5000 spectrophotomer (Agilent, Santa Clara, CA, USA)
equipped with a diffuse reflectance accessory. Data are
reported as Kubelka-Munk function.
2.3 Release tests
Release tests were performed in three different solutions.
A Phosphate Buffer Saline solution (PBS) 0.01 M, pH=
7.4, was obtained by dissolving commercial tablets
(Sigma-Aldrich, Milano, Italy) in distilled water to mimic
plasma. A 0.1 M HCl solution (pH= 0.8), which repro-
duced the gastric conditions, was prepared with HCl 37
wt.% (Sigma-Aldrich, Milano, Italy) and distilled water.
Artificial sweat (AS), which reproduced the topical
environment, was prepared according to Shimamura et al.
[22] by dissolving 2.34 g NaCl, 0.13 g CaCl2, 0.10 g
MgSO4, and 0.82 g KH2PO4 in 800 g of distilled water and
finally adjusting the pH to the value of 5.4 by adding a
0.05 M NaOH solution (all reagents were purchased by
Sigma-Aldrich, Milano, Italy, except for CaCl2 that was
provided by Merck, Milano, Italy). Release tests were
carried out in an Erweka DT tester (Erweka, Langen,
Germany) at 37 °C under stirring (100 rpm). Absorption of
the release medium was constantly monitored at 425 nm
for PBS, 429 nm for the HCl solution, and 427 nm for AS
for 20 h in a Lambda 25 spectrophotometer (Perkin Elmer,
Waltham, MA, USA).
3 Results
3.1 Synthesis
The synthesis process led to the production of ~650mg of
the reference material; a similar amount was obtained as far
as the curcumin-loaded material is concerned. As shown in
Fig. 1, the reference material (hereafter named “Meso_SiO2”)
appeared as a white powder, while the one containing cur-
cumin (named “Meso_SiO2_Cur”) displayed a red color,
which visually confirms the presence of curcumin inside the
material. It is worth noting that crystalline curcumin is not
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red, but rather bright yellow-orange (Fig. 1c). The darker
color of Meso_SiO2_Cur was ascribed to the deprotonation
of curcumin, which typically causes this bathochromic
effect [1]. In fact, since the synthesis takes place in a basic
solution, curcumin in the final material is in its deprotonated
form.
Moreover, it must be underlined that the filtered synth-
esis solution was reddish (Appendix Fig. 10a), which sug-
gests that part of the curcumin was not incorporated in the
material, but remained in the synthesis solution.
Finally, it is worth noting that the present synthesis
procedure differs from similar works reported in the lit-
erature, such as the one by Chin et al. [18] since it was
carried out in basic conditions (instead of the acidic ones),
required a shorter time (few hours rather than days) and did
not imply the use of toxic organic reagents, such as
formamide.
3.2 Characterization
Figure 2a reports the XRD patterns obtained at small angles
for the reference material Meso_SiO2 and for the one con-
taining curcumin, Meso_SiO2_Cur. In both spectra, three
peaks are visible, respectively at 2θ values of 2.13, 3.64,
and 4.27 for Meso_SiO2 and of 2.07, 3.54, and 4.08 for
Meso_SiO2_Cur. For both samples, the three peaks evi-
dence the 2D hexagonal symmetry of a mesostructured
material and they correspond to the reflections (100), (110),
and (200), respectively. In addition, a fourth peak is visible
in the pattern of Meso_SiO2 at 2θ equal to 5.61, which is
due to the reflection (210).
It can be noticed that all peaks in the Meso_SiO2_Cur
sample are shifted toward lower angles with respect to those
of Meso_SiO2. As a consequence, the cell parameter a,
which can be calculated from the knowledge of d(100) and on
the basis of the a= 2d(100)/√3 geometrical assumption [23],
is equal to 4.80 nm for Meso_SiO2 and 4.95 nm for
Meso_SiO2_Cur, respectively.
Figure 2b shows the diffraction pattern at high angles of
the two synthesized materials and of the crystalline curcu-
min as received. While crystalline curcumin displays sev-
eral peaks, where the major ones are at 2θ= 17.51 and 2θ
= 9.03, no peaks are observed either in the reference
material or in the curcumin-loaded one.
Figure 3 displays the FESEM images of the reference
material (Fig. 3a) and of the curcumin-loaded one (Fig. 3b).
The particles of Meso_SiO2 are characterized by a regular
morphology, with hexagonal shape and a size of about
Fig. 2 a XRD patterns of Meso_SiO2 (1) and Meso_SiO2_Cur (2) at small angles. b XRD patterns of crystalline curcumin (1), Meso_SiO2 (2), and
Meso_SiO2_Cur (3) at high angles
Fig. 1 Photos of Meso_SiO2 (a),
Meso_SiO2_Cur (b), and
crystalline curcumin (c) powders
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500–600 nm. Meso_SiO2_Cur, instead, shows rod-like
particles long up to 700–800 nm (some of them with a
hexagonal-shaped section) as well as some discoid particles
of 500–600 nm in diameter.
FTIR spectra of the synthesized materials, which were
outgassed at room temperature, are reported in Fig. 4. In the
spectrum of Meso_SiO2, the weak peak at about 3700 cm
−1
is due to the stretching mode of silanols, while bands in the
range 2950–2850 cm−1 and 1500–1400 cm−1 are attributed,
respectively, to the stretching modes of the –CH2– and
–CH3 groups and to the bending modes of the N–CH2–
groups of the surfactant molecules [24]. The spectrum of
Meso_SiO2_Cur is characterized by the same bands as the
reference material as well as other additional peaks, which
are observed in the range between 1600 and 1530 cm−1 and
are ascribed to the stretching vibrations of the aromatic
rings of curcumin [25, 26].
Figure 5 reports the UV–Vis spectrum of the Meso_-
SiO2_Cur powder (curve 1); since Meso_SiO2 did not
present any peak in the analysed range, its spectrum is not
reported for sake of simplicity. The spectrum reported in
Fig. 5 reveals a broad band centred at 476 nm (coherently
with the red color of the powder). The inset in Fig. 5 dis-
plays the adsorption spectrum of curcumin dissolved in a
0.05M NaOH alkaline solution (with the addition of around
10 wt.% ethanol in order to increase the solubility of cur-
cumin at a detectable level), for comparison. The spectra of
the solid powder and the curcumin alkaline solution are
quite similar. The band of the curcumin basic solution
(468 nm) is shifted only by a few nanometers with respect
to that of the solid powder (476 nm).
Fig. 3 FESEM images of
Meso_SiO2 (a) and
Meso_SiO2_Cur (b)
Fig. 4 FT-IR spectra of Meso_SiO2 (dark gray, 1) and Meso_SiO2_Cur
(black, 2) outgassed at room temperature
Fig. 5 UV–Vis spectra of Meso_SiO2_Cur powder (1). Inset (2) shows
the UV–Vis spectrum of curcumin (7 ppm) in a 0.05M solution
of NaOH
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3.3 Release tests
A first result is that no residual material was observed at the
end of the tests in PBS and AS, while a yellow residual
powder was retrieved after the test in HCl solution.
Figure 6 reports the absorption spectrum of the AS
solution, which was measured at the end of the release test,
i.e., after immersing Meso_SiO2_Cur at 37 °C for 20 h. A
similar spectrum was obtained at the end of the release test
in PSB. A structured absorption with a maximum at 422 nm
is observed, due to the dissolved curcumin that was released
from the material upon immersion.
As far as the kinetics of release is concerned, results are
reported in Fig. 7: the amount of the curcumin released from
the carrier in different media is represented as a function of
time.
In the HCl solution, negligible release was observed.
On the opposite, curcumin was released from the carrier
both in PBS and in AS. In detail, in PBS the release
started 1 h after the immersion of the sample, then the
amount of released curcumin rapidly increased until a
plateau was reached after 5 h. When the carrier was
immersed in AS, the curcumin was released after a 2 h
delay. Again, curcumin was then rapidly released, and
the plateau was reached at around 12 h. The total amount
of released curcumin can be used to evaluate the content
of curcumin in the carrier, which corresponds to about
5 wt.%.
As a comparison, the dissolution of crystalline cur-
cumin in PBS is also reported in Fig. 7: no release of the
drug was detected for the whole duration of the test.
Similar results (not reported) were obtained for the dis-
solution of crystalline curcumin in the other media (AS
and HCl solution).
4 Discussion
4.1 Characterization
Both synthesized materials are amorphous with an ordered
hexagonal mesostructure typical of MCM-41 silica [21], as
revealed by the peaks at small angles in the X-ray diffrac-
tion patterns (Fig. 2a). The corresponding cell parameters,
derived from the position of the peak d(100), show a slightly
higher value for Meso_SiO2_Cur (4.95 nm) with respect to
Meso_SiO2 (4.80 nm), so suggesting that the presence of
curcumin causes a swelling of the micelles. It is worth
noting that the curcumin present in the hybrid carrier is not
crystalline (Fig. 2b), contrary to what observed for curcu-
min in silica nanoparticles [16], and, therefore, it is
expected to be more bioavailable.
The presence of curcumin also causes the change of the
particles morphology observed by FESEM (Fig. 3).
Whereas the hexagonal shape typical of MCM-41 silica is
partially maintained in the reference material, the particles
become more elongated or assume a discoid-shape when
curcumin is embedded. This is coherent with what observed
by other authors when a dye was added during the synthesis
of mesoporous silica [27]. The above-mentioned impact on
the particle shape that results from drug incorporation is a
proof that curcumin has an influence on the co-assembly
process and may act as a co-templating agent.
FT-IR results confirm the presence of both surfactant and
curcumin (Fig. 4). The weak intensity of the band due to
silanols is in agreement with the expected interface between
silica and micelles for materials synthesized in alkaline
conditions, i.e., a strong interaction between the negatively
charged silica network and the positively charged
surfactant.
In a similar manner the keto-enol and the hydroxyl
groups of curcumin are deprotonated (therefore they are
negatively charged) and can interact with the positive-
charged surfactant. This means that the interactions of
curcumin inside the carrier could be not only hydrophobic,
but also ionic. This implies that, probably, curcumin is not
segregated in the core of the surfactant micelles, but it is
rather located more closely to the interface between the
surfactant and silica, similarly to what observed in a pre-
vious work for another dye [20]. Furthermore, this could
explain why the embedding of curcumin does not cause
only a simple swelling of the hybrid mesostructure (as
observed by the XRD analyses in Fig. 2a), but also alters
the morphology of the final particles (FESEM images in
Fig. 3b), so acting as a co-templating agent.
Another evidence of the strong interactions involving
curcumin inside the carrier is provided by washing the
Meso_SiO2_Cur powder with different solvents (Appendix
Figs 10, 11). When washed with water, the powder did not
Fig. 6 UV–Vis absorption spectra of artificial sweat solution (AS) at
the end of the release test from Meso_SiO2_Cur
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release any curcumin (Appendix Fig. 10b-c-b′-c′), whereas,
when washed with ethanol, the leaching of curcumin was
observed (Appendix Fig. 11a). These results confirm that
the powder can be washed with water to remove any pos-
sible excess of synthesis reactant without removing curcu-
min. Since curcumin is part of the internal micelles, water
does not cause any leaching. To remove curcumin from the
carrier the use of a solvent with higher affinity, such as
ethanol, is necessary. Interestingly, when washed with
ethanol, the powder not only became white (because of the
curcumin loss, Appendix Fig. 11b) but also lost its
mesostructure (Appendix Fig. 12). This could be explained
by supposing that ethanol is able to remove both the cur-
cumin and partially the surfactant so inducing a loss of
order in the material.
The UV–Vis spectra of the Meso_SiO2_Cur powder
confirm the state of curcumin in the hybrid material. The
absorption peak at around 476 nm (Fig. 5) is attributed to
the curcumin in the deprotonated form [1]. This is coherent
with the alkaline environment of the synthesis conditions
and suggests that, being curcumin negatively charged, it can
interact with the cationic surfactant through electrostatic
interactions.
As a conclusion, it can be stated that a hybrid mesos-
tructured material containing curcumin molecules has been
successfully synthesized. According to the evidences pro-
vided by different characterization techniques, a schematic
representation of the hybrid material can be sketched, as
reported in Fig. 8. It can be hypothesized that curcumin
does not segregate in the inner core of the hybrid material,
but is rather dissolved in the surfactant and it may also be
located at or close to the interface between the surfactant
and silica. Due to possible strong electrostatic interactions
between the deprotonated curcumin molecules and
surfactant cationic heads, curcumin may act as a co-
templating agent in the co-assembly of the mesostructured,
so affecting the growth and the morphology of the particles.
4.2 Release tests
Since the main aim of the present work is to increase water
solubility of curcumin, release tests in different water-based
solutions mimicking different physiological conditions were
performed.
Even though curcumin is hydrophobic and the
curcumin–surfactant interactions are quite strong, the drug
could be released from the Meso_SiO2_Cur carrier both in
PBS and AS (Fig. 7). Interestingly, although curcumin
inside the hybrid material is deprotonated, as soon as it is
released into an aqueous solution, it becomes protonated, as
proved by the UV absorption wavelength of around
420–425 nm (Fig. 6). Therefore, the hybrid carrier is suc-
cessful in increasing the solubility of curcumin in water
without compromising its efficacy. Indeed, curcumin must
be delivered in a protonated form to maintain its beneficial
Fig. 8 Schematic representation of the hybrid Meso_SiO2_Cur
material
Fig. 7 Curcumin release curves
from Meso_SiO2_Cur in HCl
solution (light gray, 2), PBS
(dark gray, 3), and artificial
sweat (AS, black, 4). Release
curve of crystalline curcumin in
PBS (dark gray bolt line, 1) is
reported for comparison. Error
bars refer to instrument
uncertainty
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properties in the human body since deprotonation is
expected to occur during the antioxidant mechanism played
by the drug [1].
As far as the release kinetics of the drug, both in PBS and
in AS, is concerned, no burst release was observed. The
drug release started after a specific lag time (1 h in PBS and
2 h in AS): it, then, rapidly increased and, finally, reached a
plateau. The presence of an initial lag time as well as the
absence of residual powder at the end of the test, may
induce to think that the release mechanism of curcumin in
PBS and in AS involves the degradation of the amorphous
silica matrix. On the opposite, almost no curcumin was
released in the HCl solution and a significant amount of
yellow powder was retrieved at the end of the test. At acidic
pH the carrier does not undergo any significant degradation
process and, therefore, the release amount of curcumin was
negligible. Finally, no release at all was observed when
crystalline curcumin was dispersed in the solutions; in fact,
crystalline curcumin is hydrophobic with very low solubi-
lity in water.
As far as the tests in the PBS and AS solutions are
concerned, if, as previously hypothesized, curcumin is
released upon degradation of the carrier, the active principle
is delivered together with silicates and the surfactant
micelles. These in solution can confine curcumin and
increase its solubility. It is, in fact, reported in the literature
that when a critical micellar concentration is overcome,
surfactants can solubilize hydrophobic molecules [28, 29].
The presence of curcumin-containing micelles can be
proved by the observation of the UV absorption spectrum in
AS (Fig. 6). The spectrum, in fact, is comparable to that
reported in the literature [6] for curcumin dissolved in CTA-
micelles solution.
On the basis of the whole set of results, it can be con-
cluded that the synthesized Meso_SiO2_Cur carrier suc-
ceeds in protecting and conveying curcumin both in PBS
and AS, which mimic plasma and a topical environment,
respectively. On the other hand, the carrier results ineffec-
tive in releasing the drug in simulated gastric conditions
(i.e., a HCl solution).
Interestingly, once released, curcumin becomes proto-
nated again, recovering its active status. The initial lag time
and the absence of powder at the end of the release tests
suggest that the release may be also triggered by phenom-
ena of silica degradation. Consequently, as schematically
depicted in Fig. 9, not only curcumin, but also silicates and
surfactant are released from the hybrid carrier. This can be
particularly appealing in view of potential applications of
this material in the topical field. Silicon, in fact, can posi-
tively affect normal skin formation, since this element dis-
plays plastic, trophic, and anti-inflammatory functions [30].
On the other hand, regarding the release of surfactant, it
must be pointed out that, at high concentrations, CTA
surfactant can be toxic [31, 32]; therefore, it is envisaged to
substitute CTA with a nontoxic surfactant with biological
properties. Further studies in this sense are currently under
investigation. Nevertheless, the cytotoxicity of CTA could
instead be exploited in the formulation of materials for the
treatment of cancer or precancer pathologies [33].
5 Conclusions
In this study, a hybrid material containing amorphous cur-
cumin, CTA, and silica has been successfully synthesized
(Meso_SiO2_Cur). In absence of curcumin, a reference
hybrid material made of CTA and silica was obtained
(Meso_SiO2). The proposed synthesis process is an organic-
solvent-free, rapid one-pot procedure that is conducted at
mild conditions and can be easily adapted for the incor-
poration of other hydrophobic active principles. This novel
approach allows the direct incorporation of the active
principle during the synthesis process to be obtained, so
eliminating the need of any loading procedure and the use
of dangerous solvents.
Both the reference material and the curcumin-loaded one
are mesostructured. The addition of curcumin results in the
modification of the particles morphology. This probably
occurs because curcumin acts not as a simple swelling
agent, but rather as a co-templating agent, since it assumes a
negative charge and can closely interact with the cationic
surfactant species.
When Meso_SiO2_Cur undergoes the release tests, cur-
cumin is gradually and completely released both in PBS and
in AS, where it recovers its protonated active form. Dif-
ferently from what is usually observed in the literature for
silica carriers, the release mechanism of this hybrid material
is reasonably governed by a degradation process of the
silica matrix. Therefore, not only curcumin, but also sur-
factant and silicates are released. Thanks to the presence of
the surfactant micelles, the water solubility of curcumin is
significantly increased. While the release of the cytotoxic
Fig. 9 Schematic representation of the release from hybrid material
Meso_SiO2_Cur
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CTA could be advantageous for the formulation of materials
to treat cancer or precancer pathologies, the release of sili-
cates can be beneficial to the skin due to its trophic func-
tions, so confirming the interest of this carrier for topical
applications.
Finally, since the carrier does not undergo any significant
degradation in the HCl solution, no curcumin is released in
acidic media. This characteristic opens the route for another
possible application of the carrier as a gastro protector.
Indeed, the proposed carrier could pass through the stomach
without releasing the active principle, which could be
subsequently released in the intestine where the pH is
less acid.
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6 Appendix
Additional figures concerning the synthesis process and
washing procedure are here reported.
Figs 10–12
Fig. 10 Filtered synthesis solution of Meso_SiO2_Curc (a) and water
filtered after washing Meso_SiO2_Curc (once, b, or twice, c) with
water. The wet Meso_SiO2_Curc material after one (b′) or two (c′)
washing steps with water are reported in the lower part of the image
Fig. 11 Meso_SiO2_Curc during
(a) and after (b) the washing
with ethanol
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